Interleukin-2 and histamine dihydrochloride in metastatic melanoma

被引:4
作者
Agarwala, SS [1 ]
Hellstrand, K
Naredi, P
机构
[1] Univ Pittsburgh, Melanoma Ctr, Pittsburgh, PA 15260 USA
[2] Gothenburg Univ, S-41124 Gothenburg, Sweden
[3] Umea Univ, S-90187 Umea, Sweden
关键词
D O I
10.1200/JCO.2002.99.302
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:3558 / 3559
页数:2
相关论文
共 2 条
[1]   Results from a randomized phase III study comparing combined treatment with histamine dihydrochloride plus interleukin-2 versus interleukin-2 alone in patients with metastatic melanoma [J].
Agarwala, SS ;
Glaspy, J ;
O'Day, SJ ;
Mitchell, M ;
Gutheil, J ;
Whitman, E ;
Gonzalez, R ;
Hersh, E ;
Feun, L ;
Belt, R ;
Meyskens, F ;
Hellstrand, K ;
Wood, D ;
Kirkwood, JM ;
Gehlsen, KR ;
Naredi, P .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (01) :125-133
[2]   Are all hypotheses generated before data analysis prospective? [J].
Urba, WJ ;
Alvord, WG .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (06) :1431-1433